Search

Your search keyword '"PLOUX, SYLVAIN"' showing total 587 results
Start Over Author "PLOUX, SYLVAIN"
587 results on '"PLOUX, SYLVAIN"'

1. Distinct Substrates of Idiopathic Ventricular Fibrillation Revealed by Arrhythmia Characteristics on Implantable Cardioverter-Defibrillator

Author

Haïssaguerre, Michel, Sellal, Jean-Marc, Benali, Karim, de Becker, Benjamin, Defaye, Pascal, Pascale, Patrizio, Martins, Raphael, Mabo, Philippe, Xhaet, Olivier, Extramiana, Fabrice, Surget, Elodie, Lavergne, Thomas, Marijon, Eloi, Adragao, Pedro, Carvalho, Maria Salomé, Milliez, Paul-Ursmar, Laredo, Mickael, Gandjbakhch, Estelle, Giustetto, Carla, Gaita, Fiorenzo, Tilz, Roland, Jesel-Morel, Laurence, Steinfurt, Johannes, Arentz, Thomas, Knecht, Sebastien, Duytschaever, Mattias, Roten, Laurent, Reichlin, Tobias, Fatemi, Marjaneh, Mansourati, Jacques, Kouakam, Claude, Bessière, Francis, Chevalier, Philippe, Tadros, Rafik, Macle, Laurent, Gallego, Francisco, Hadjis, Alexios, Sacher, Frederic, Pereira, Dylan, Hourdain, Jerome, Deharo, Jean-Claude, Eschalier, Romain, Massoulié, Grégoire, Maury, Philippe, Latcu, Decebal Gabriel, Anselme, Frederic, Duchateau, Josselin, Tixier, Romain, Nademanee, Koonlawee, Nogami, Akihiko, de Groot, Natasja, Vigmond, Edward, Bernus, Olivier, Strik, Marc, Bordachar, Pierre, Cathala, Aude, Bouteiller, Xavier, Dubois, Remi, and Ploux, Sylvain

Published
2024
Full Text
View/download PDF

5. Artificial intelligence for detection of ventricular oversensing: Machine learning approaches for noise detection within nonsustained ventricular tachycardia episodes remotely transmitted by pacemakers and implantable cardioverter-defibrillators

Author

Strik, Marc, Sacristan, Benjamin, Bordachar, Pierre, Duchateau, Josselin, Eschalier, Romain, Mondoly, Pierre, Laborderie, Julien, Gassa, Narimane, Zemzemi, Nejib, Laborde, Maxime, Garrido, Juan, Matencio Perabla, Clara, Jimenez-Perez, Guillermo, Camara, Oscar, Haïssaguerre, Michel, Dubois, Rémi, and Ploux, Sylvain

Published
2023
Full Text
View/download PDF

6. Incidence of premature battery depletion in subcutaneous cardioverter-defibrillator patients: insights from a multicenter registry

Author

Lüker, Jakob, Strik, Marc, Andrade, Jason G., Raymond-Paquin, Alexandre, Elrefai, Mohamed Hassan, Roberts, Paul R., Pérez, Óscar Cano, Kron, Jordana, Koneru, Jayanthi, Franqui-Rivera, Hilton, Sultan, Arian, Ernst, Angela, Schmitt, Jörn, Pott, Alexander, Veltmann, Christian, Srinivasan, Neil T, Collinson, Jason, van Stipdonk, Antonius M. W., Linz, Dominik, Fluschnik, Nina, Tönnis, Tobias, Haeberlin, Andreas, Ploux, Sylvain, and Steven, Daniel

Published
2023
Full Text
View/download PDF

7. Incidence and management of atrioventricular conduction disorders in new-onset left bundle branch block after TAVI: A prospective multicenter study

Author

Massoullié, Grégoire, Ploux, Sylvain, Souteyrand, Géraud, Mondoly, Pierre, Pereira, Bruno, Amabile, Nicolas, Jean, Frédéric, Irles, Didier, Mansourati, Jacques, Combaret, Nicolas, Mechulan, Alexis, Badoz, Marc, Da Costa, Antoine, Defaye, Pascal, Motreff, Pascal, Clerfond, Guillaume, Bordachar, Pierre, and Eschalier, Romain

Published
2023
Full Text
View/download PDF

9. Incidence, Implications, and Management of Sense-B-Noise Failure in Subcutaneous Cardioverter-Defibrillator Patients: insights from a large Multicenter Registry

Author

Wörmann, Jonas, primary, Strik, Marc, additional, Jurisic, Stjepan, additional, Stout, Kara, additional, Elrefai, Mohamed, additional, Becher, Nina, additional, Schaer, Beat, additional, van Stipdonk, Antonius, additional, Srinivasan, Neil T, additional, Ploux, Sylvain, additional, Breitenstein, Alexander, additional, Kron, Jordana, additional, Roberts, Paul R, additional, Toennis, Tobias, additional, Linz, Dominik, additional, Dulai, Rajdip, additional, Hermes-Laufer, Julia, additional, Koneru, Jay, additional, Erküner, Ömer, additional, Dittrich, Sebastian, additional, van den Bruck, Jan-Hendrik, additional, Schipper, Jan-Hendrik, additional, Sultan, Arian, additional, Rosenberger, Kerstin D, additional, Steven, Daniel, additional, and Lüker, Jakob, additional

Published
2024
Full Text
View/download PDF

17. Occurrence of premature battery depletion in a large multicentre registry of subcutaneous cardioverter-defibrillator patients.

Author

Wörmann, Jonas, Strik, Marc, Jurisic, Stjepan, Stout, Kara, Elrefai, Mohamed, Becher, Nina, Schaer, Beat, Stipdonk, Antonius van, Srinivasan, Neil T, Ploux, Sylvain, Breitenstein, Alexander, Kron, Jordana, Roberts, Paul R, Toennis, Tobias, Linz, Dominik, Dulai, Rajdip, Hermes-Laufer, Julia, Koneru, Jay, Erküner, Ömer, and Dittrich, Sebastian

Abstract

Aims Subcutaneous implantable cardioverter-defibrillators (S-ICDs) have become established in preventing sudden cardiac death, with some advantages over transvenous defibrillator systems, including a lower incidence of lead failures. Despite technological advancements, S-ICD carriers may suffer from significant complications, such as premature battery depletion (PBD), that led to an advisory for nearly 40 000 patients. This multicentre study evaluated the incidence of PBD in a large set of S-ICD patients. Methods and results Data from patients implanted with S-ICD models A209 and A219 between October 2012 and July 2023 across nine centres in Europe and the USA were reviewed. Incidence and implications of PBD, defined as clinically observed sudden drop in battery longevity, were analysed and compared to PBD with the definition of battery depletion within 60 months. Prospectively collected clinical data were obtained retrospectively from medical records, device telemetry, and manufacturer reports. This registry is listed on ClinicalTrials.gov (NCT05713708). Of the 1112 S-ICD devices analysed, 547 (49.2%) were equipped with a potentially affected capacitor linked to PBD occurrence, currently under Food and Drug Administration advisory. The median follow-up time for all patients was 46 [inter-quartile range (IQR) 24–63] months. Clinically suspected PBD was observed in 159 (29.1%) of cases, with a median time to generator removal or replacement of 65 (IQR 55–72) months, indicative of significant deviations from expected battery lifespan. Manufacturer confirmation of PBD was made in 91.7% of devices returned for analysis. No cases of PBD were observed in devices that were not under advisory. Conclusion This manufacturer-independent analysis highlights a notable incidence of PBD in patients equipped with S-ICD models under advisory, and the rate of PBD in this study corresponds to the rate currently estimated by the manufacturer. To the best of our knowledge, this provides the largest contemporary peer-reviewed study cohort investigating the actual incidence of PBD in S-ICD patients. These findings emphasize the importance of post-market registries in collaboration between clinicians and the manufacturer to optimize safety and efficacy in S-ICD treatment. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

27. Effect of Optimization of Medical Treatment on Long-Term Survival of Patients With Heart Failure After Implantable Cardioverter Defibrillator and Cardiac Resynchronization Device Implantation (from the French National EGB Database)

Author

Massoullié, Grégoire, Chouki, Chenaf, Mulliez, Aurélien, Rossignol, Patrick, Ploux, Sylvain, Pereira, Bruno, Reuillard, Adrien, Jean, Fréderic, Andronache, Marius, Eschalier, Alain, Motreff, Pascal, Clerfond, Guillaume, Bordachar, Pierre, Authier, Nicolas, and Eschalier, Romain

Published
2018
Full Text
View/download PDF

28. Cardiac Rhythm Disturbances in Hemodialysis Patients: Early Detection Using an Implantable Loop Recorder and Correlation With Biological and Dialysis Parameters

Author

Sacher, Frederic, Jesel, Laurence, Borni-Duval, Claire, De Precigout, Valerie, Lavainne, Frédéric, Bourdenx, Jean-Philippe, Haddj-Elmrabet, Atman, Seigneuric, Bruno, Keller, Adrien, Ott, Julien, Savel, Helene, Delmas, Yahsou, Bazin-kara, Dorothée, Klotz, Nicolas, Ploux, Sylvain, Buffler, Sébastien, Ritter, Philippe, Rondeau, Virginie, Bordachar, Pierre, Martin, Claire, Deplagne, Antoine, Reuter, Sylvain, Haissaguerre, Michel, Gourraud, Jean-Baptiste, Vigneau, Cécile, Mabo, Philippe, Maury, Philippe, Hannedouche, Thierry, Benard, Antoine, and Combe, Christian

Published
2018
Full Text
View/download PDF

31. Risk of electromagnetic interferences and inappropriate shocks during concomitant use of subcutaneous intracardiac cardioverter-defibrillator and HeartMate 3 assist device: A multicenter registry

Author

Benali, Karim, Spittler, Raphael, Galand, Vincent, Behar, Nathalie, Marquie, Christelle, Baudinaud, Pierre, Champ-Rigot, Laure, Ploux, Sylvain, Badenco, Nicolas, Algalarrondo, Vincent, Garnier, Fabien, Maille, Baptiste, Vlachos, Konstantinos, Rakza, Redwane, Groussin, Pierre, Da Costa, Antoine, Sommer, Philipp, and Martins, Raphael

Published
2024
Full Text
View/download PDF

33. Remote management of worsening heart failure to avoid hospitalization in a real‐world setting.

Author

Ploux, Sylvain, Strik, Marc, Ramirez, F. Daniel, Buliard, Samuel, Chauvel, Rémi, Dos Santos, Pierre, Haïssaguerre, Michel, Jobbé‐Duval, Antoine, Picard, François, Riocreux, Clément, Eschalier, Romain, and Bordachar, Pierre

Subjects
HEART failure, HOSPITAL care, GLOMERULAR filtration rate, HEART failure patients, ARTIFICIAL implants
Abstract

Aims: From a patient and health system perspective, managing worsening heart failure (WHF) as an outpatient has become a priority. Remote management allows early detection of WHF, enabling timely intervention with the aim of preventing hospitalization. The objective of the study was to evaluate the feasibility and safety of remotely managing WHF events using a multiparametric platform. Methods and results: All patients enrolled in the heart failure remote management programme of the Bordeaux University Hospital Telemedicine Center between 1 January and 31 December 2021 were included in the study. Follow‐up data were collected until 1 March 2022. Inclusion criteria were chronic heart failure (HF) with New York Heart Association ≥II symptoms and an elevated B‐type natriuretic peptide (BNP > 100 pg/mL or N‐terminal‐pro‐BNP > 1000 pg/mL). Patient assessments were performed remotely and included measurements of body weight, blood pressure, heart rate, symptoms, biochemical parameters, and data from cardiac implantable electronic devices when available. In total, 161 patients (71 ± 11 years old, 79% male) were followed for a mean of 291 ± 66 days with a mean adherence to the remote monitoring system of 80 ± 20%. Over this period, 52 (32.3%) patients had 105 WHF events, of which 66 (63%) were successfully managed remotely, the remaining requiring hospitalization. Freedom from WHF events and hospitalization at 300 days were 66% and 85%, respectively (P < 0.001 for the difference). Increased level of BNP was associated with an increased risk of WHF event [hazard ratio (HR) per unit increase in BNP: 1.001; 95% confidence interval (CI) 1–1.002; P = 0.001] and hospitalization (HR 1.002; 95% CI 1.002–1.003; P = 0.002). A decrease in the level of glomerular filtration rate was associated with an increased risk of hospitalization (HR per unit decrease in estimated glomerular filtration rate: 0.946; 95% CI 0.906–0.989; P = 0.014). WHF event recurrence and (re)hospitalization rates at 1‐month were similar among patients managed remotely (18% and 12%, respectively) and those requiring hospitalization (21% and 10%, respectively). Iatrogenic complications occurred more often during hospitalization than remote management (26% vs. 3%, P < 0.001). Conclusions: Our study suggests that remote management of WHF events based on a multiparametric approach led by a telemedical centre is feasible and safe. Adopting such a strategy for patients with chronic HF could reduce HF‐related hospitalizations with expected benefits for patients, care providers, and health care systems. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

36. Artificial Intelligence for Detection of Ventricular Oversensing Machine Learning Approaches for Noise Detection Within Non-Sustained Ventricular Tachycardia Episodes Remotely Transmitted by Pacemakers and Implantable Cardioverter Defibrillators

Author

Strik, Marc, Sacristan, Benjamin, Bordachar, Pierre, Duchateau, Josselin, Eschalier, Romain, Mondoly, Pierre, Laborderie, Julien, Gassa, Narimane, Zemzemi, Nejib, Laborde, Maxime, Garrido, Juan, Perabla, Clara Matencio, Jimenez-Perez, Guillermo, Camara, Oscar, Haïssaguerre, Michel, Dubois, Rémi, Ploux, Sylvain, Centre Hospitalier Universitaire de Bordeaux (CHU de Bordeaux), IHU-LIRYC, Université Bordeaux Segalen - Bordeaux 2-CHU Bordeaux [Bordeaux], CHU Clermont-Ferrand, Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Service de cardiologie [Centre Hospitalier de la Côte Basque, Bayonne], Centre Hospitalier de la Côte Basque (CHCB), Université de Bordeaux (UB), Inria Bordeaux - Sud-Ouest, Institut National de Recherche en Informatique et en Automatique (Inria), Universitat Pompeu Fabra [Barcelona] (UPF), ANR-10-IAHU-0004,LIRYC,L'Institut de Rythmologie et modélisation Cardiaque(2010), European Project: 860974,PersonalizeAF(2020), and University Hospital Rangueil, Toulouse

Subjects
[STAT.ML]Statistics [stat]/Machine Learning [stat.ML], [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, [SDV.IB]Life Sciences [q-bio]/Bioengineering, [SPI.SIGNAL]Engineering Sciences [physics]/Signal and Image processing
Abstract

International audience; Background:Pacemakers (PMs) and implantable cardioverter defibrillators (ICDs) increasingly automatically record and remotely transmit non-sustained ventricular tachycardia (NSVT) episodes which may reveal ventricular oversensing.Objectives:We aimed to develop and validate a machine learning algorithm which accurately classifies NSVT episodes transmitted by PMs and ICDs in order to lighten healthcare workload burden and improve patient safety.Methods:PMs or ICDs (Boston Scientific) from four French hospitals with ≥1 transmitted NSVT episode were split into three subgroups: training set, validation set, and test set. Each NSVT episode was labelled as either physiological or non-physiological. Four machine learning algorithms (2DTF-CNN, 2D-DenseNet, 2DTF-VGG, and 1D-AgResNet) were developed using a training and validation dataset. Accuracies of the classifiers were compared with an analysis of the remote monitoring team of the Bordeaux University Hospital using F2 scores (favoring sensitivity over predictive positive value) using an independent test set.Results:807 devices transmitted 10.471 NSVT recordings (82% ICD, 18% PM), of which 87 devices (10.8%) transmitted 544 NSVT recordings with non-physiological signals. The classification by the remote monitoring team resulted in an F2 score of 0,932 (sensitivity of 95%, specificity of 99%) The four machine learning algorithms showed high and comparable F2 scores (2DTF-CNN: 0,914, 2D-DenseNet: 0,906, 2DTF-VGG: 0,863, 1D-AgResNet: 0,791) and only 1D-AgResNet had significantly different labeling as compared with the remote monitoring team.Conclusion:Machine learning algorithms were accurate in detecting non-physiological signals within EGMs transmitted by pacemaker and ICDs. An artificial intelligence approach may render remote monitoring less resourceful and improve patient safety.

Published
2023

37. Ability to remotely monitor atrial high-rate episodes using a single-chamber implantable cardioverter-defibrillator with a floating atrial sensing dipole

Author

Hindricks, Gerhard, primary, Theuns, Dominic A, additional, Bar-Lev, David, additional, Anguera, Ignasi, additional, Ayala Paredes, Félix Alejandro, additional, Arnold, Martin, additional, Geller, J Christoph, additional, Merkely, Béla, additional, Dyrda, Katia Marjolaine, additional, Perings, Christian, additional, Maglia, Giampiero, additional, Ploux, Sylvain, additional, Meyhöfer, Jürgen, additional, Blomström-Lundqvist, Carina, additional, Karjalainen, Pasi, additional, Liang, Yanchun, additional, Diemberger, Igor, additional, Wranicz, Jerzy Krzysztof, additional, Barr, Craig, additional, Quartieri, Fabio, additional, Timmel, Tobias, additional, and Bollmann, Andreas, additional

Published
2023
Full Text
View/download PDF

38. Insertable cardiac monitor with a long sensing vector: Impact of obesity on sensing quality and safety

Author

Bisignani, Giovanni, primary, De Bonis, Silvana, additional, Pierre, Bertrand, additional, Lau, Dennis H., additional, Hofer, Daniel, additional, Sanfins, Victor Manuel, additional, Hain, Andreas, additional, Cabanas, Pilar, additional, Martens, Eimo, additional, Berruezo, Antonio, additional, Eschalier, Romain, additional, Milliez, Paul, additional, Lüsebrink, Ulrich, additional, Mansourati, Jacques, additional, Papaioannou, Georgios, additional, Giacopelli, Daniele, additional, Gargaro, Alessio, additional, and Ploux, Sylvain, additional

Published
2023
Full Text
View/download PDF

41. Ability to remotely monitor atrial high-rate episodes using a single-chamber implantable cardioverter-defibrillator with a floating atrial sensing dipole

Author

Hindricks, Gerhard, Theuns, Dominic A., Bar-Lev, David, Anguera, Ignasi, Ayala Paredes, Félix Alejandro, Arnold, Martin, Geller, J. Christoph, Merkely, Béla, Dyrda, Katia Marjolaine, Perings, Christian, Maglia, Giampiero, Ploux, Sylvain, Meyhöfer, Jürgen, Blomström-Lundqvist, Carina, Karjalainen, Pasi, Liang, Yanchun, Diemberger, Igor, Wranicz, Jerzy Krzysztof, Barr, Craig, Quartieri, Fabio, Timmel, Tobias, Bollmann, Andreas, Hindricks, Gerhard, Theuns, Dominic A., Bar-Lev, David, Anguera, Ignasi, Ayala Paredes, Félix Alejandro, Arnold, Martin, Geller, J. Christoph, Merkely, Béla, Dyrda, Katia Marjolaine, Perings, Christian, Maglia, Giampiero, Ploux, Sylvain, Meyhöfer, Jürgen, Blomström-Lundqvist, Carina, Karjalainen, Pasi, Liang, Yanchun, Diemberger, Igor, Wranicz, Jerzy Krzysztof, Barr, Craig, Quartieri, Fabio, Timmel, Tobias, and Bollmann, Andreas

Abstract

Aims: To allow timely initiation of anticoagulation therapy for the prevention of stroke, the European guidelines on atrial fibrillation (AF) recommend remote monitoring (RM) of device-detected atrial high-rate episodes (AHREs) and progression of arrhythmia duration along pre-specified strata (6 min...<1h, 1 h...<24 h, >= 24h). We used the MATRIX registry data to assess the capability of a single-lead implantable cardioverter-defibrillator (ICD) with atrial sensing dipole (DX ICD system) to follow this recommendation in patients with standard indication for single-chamber ICD. Methods and results: In 1841 DX ICD patients with daily automatic RM transmissions, electrograms of first device-detected AHREs per patient in each duration stratum were adjudicated, and the corresponding positive predictive values (PPVs) for the detections to be true atrial arrhythmia were calculated. Moreover, the incidence and progression of new-onset AF was assessed in 1451 patients with no AF history. A total of 610 AHREs >= 6min were adjudicated. The PPV was 95.1% (271 of 285) for episodes 6min...<1h, 99.6% (253/254) for episodes 1 h...<24h, 100% (71/71) for episodes >= 24h, or 97.5% for all episodes (595/610). The incidence of new-onset AF was 8.2% (119/1451), and in 31.1% of them (37/119), new-onset AF progressed to a higher duration stratum. Nearly 80% of new-onset AF patients had high CHA(2)DS(2)-VASc stroke risk, and 70% were not on anticoagulation therapy. Age was the only significant predictor of new-onset AF. Conclusion: A 99.7% detection accuracy for AHRE >= 1h in patients with DX ICD systems in combination with daily RM allows a reliable guideline-recommended screening for subclinical AF and monitoring of AF-duration progression., The study was supported by Biotronik SE & Co. KG (Woermannkehre 1, D-12359 Berlin, Germany).

Published
2023
Full Text
View/download PDF

42. Insertable cardiac monitor with a long sensing vector: Impact of obesity on sensing quality and safety

Author

Bisignani, Giovanni, De Bonis, Silvana, Pierre, Bertrand, Lau, Dennis H, Hofer, Daniel, Sanfins, Victor Manuel, Hain, Andreas, Cabanas, Pilar, Martens, Eimo, Berruezo, Antonio, Eschalier, Romain, Milliez, Paul, Lüsebrink, Ulrich, Mansourati, Jacques, Papaioannou, Georgios, Giacopelli, Daniele, Gargaro, Alessio, Ploux, Sylvain, Bisignani, Giovanni, De Bonis, Silvana, Pierre, Bertrand, Lau, Dennis H, Hofer, Daniel, Sanfins, Victor Manuel, Hain, Andreas, Cabanas, Pilar, Martens, Eimo, Berruezo, Antonio, Eschalier, Romain, Milliez, Paul, Lüsebrink, Ulrich, Mansourati, Jacques, Papaioannou, Georgios, Giacopelli, Daniele, Gargaro, Alessio, and Ploux, Sylvain

Abstract

BACKGROUND Fat layers in obese patients can impair R-wave detection and diagnostic performance of a subcutaneous insertable cardiac monitor (ICM). We compared safety and ICM sensing quality between obese patients [body mass index (BMI) ≥ 30 kg/m$^{2}$] and normal-weight controls (BMI <30 kg/m$^{2}$) in terms of R-wave amplitude and time in noise mode (noise burden) detected by a long-sensing-vector ICM. MATERIALS AND METHODS Patients from two multicentre, non-randomized clinical registries are included in the present analysis on January 31, 2022 (data freeze), if the follow-up period was at least 90 days after ICM insertion, including daily remote monitoring. The R-wave amplitudes and daily noise burden averaged intraindividually for days 61-90 and days 1-90, respectively, were compared between obese patients (n = 104) and unmatched (n = 268) and a nearest-neighbour propensity score (PS) matched (n = 69) normal-weight controls. RESULTS The average R-wave amplitude was significantly lower in obese (median 0.46 mV) than in normal-weight unmatched (0.70 mV, P < 0.0001) or PS-matched (0.60 mV, P = 0.003) patients. The median noise burden was 1.0% in obese patients, which was not significantly higher than in unmatched (0.7%; P = 0.056) or PS-matched (0.8%; P = 0.133) controls. The rate of adverse device effects during the first 90 days did not differ significantly between groups. CONCLUSION Although increased BMI was associated with reduced signal amplitude, also in obese patients the median R-wave amplitude was >0.3 mV, a value which is generally accepted as the minimum level for adequate R-wave detection. The noise burden and adverse event rates did not differ significantly between obese and normal-weight patients.Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT04075084 and NCT04198220.

Published
2023

46. Low fibrosis biomarker levels predict cardiac resynchronization therapy response

Author

Massoullié, Grégoire, Sapin, Vincent, Ploux, Sylvain, Rossignol, Patrick, Mulliez, Aurélien, Jean, Frédéric, Marie, Pierre-Yves, Merlin, Charles, Pereira, Bruno, Andronache, Marius, Motreff, Pascal, Chabin, Xavier, Sellal, Jean-Marc, Citron, Bernard, Lusson, Jean-René, Vorilhon, Charles, Clerfond, Guillaume, Bordachar, Pierre, Zannad, Faiez, and Eschalier, Romain

Published
2019
Full Text
View/download PDF

47. Implantation of a leadless pacemaker in young adults

Author

Strik, Marc, primary, Nicolas, Clementy, additional, Mondoly, Pierre, additional, Eschalier, Romain, additional, Ramirez, F. Daniel, additional, Hugo‐Pierre, Racine, additional, Haïssaguerre, Michel, additional, Ritter, Philippe, additional, Ploux, Sylvain, additional, and Pierre, Bordachar, additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results